Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rotundine crystal B-type solid matter and preparation method as well as applications

A solid substance, rotundine technology, applied in the field of medicine, can solve problems such as poor absorption

Active Publication Date: 2010-12-08
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF15 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the poor absorption of rotundine itself, rotundine hydrochloride tablets were developed to promote its absorption.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rotundine crystal B-type solid matter and preparation method as well as applications
  • Rotundine crystal B-type solid matter and preparation method as well as applications
  • Rotundine crystal B-type solid matter and preparation method as well as applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel crystal-type state of rotundine solid chemical matter, which is shown as the formula (I), a preparation method of the novel crystal-type sample, and superior clinical therapeutic action of the novel crystal-type matter of the rotundine as active components in the preparation and the development of various formulations and medicament compositions for preventing and treating pains caused by various reasons, including headache, cramp, labour pains, and the like, and diseases caused by pains, such as insomnia, arrhythmia, and the like. Compared with the traditional officinal crystal-type solid matter (Crystal A type), the two types of novel crystal-type solid matter of the rotundine have higher absorption and blood concentration. Different crystal-type matter can influence the absorption speed and the blood concentration in an organism as well as the bioavailability of the active components of the medicaments, and thereby influencing the preventive and therapeutic effect of the medicaments in clinical applications.

Description

technical field The invention relates to a crystal B type substance of rotundine, which belongs to the technical field of medicine. Background technique Rotundine, chemical name is 2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]thiazine, specific rotation is -290 °~-300°, the structural formula is as follows: Luotong was designated as the second part of the 2005 edition of "Chinese Pharmacopoeia" [1] The drug category is recorded. At present, the drug includes rotundine tablet (page 339), rotundine hydrochloride tablet (page 536), and rotundine sulfate injection (page 339). Because rotundine drug itself has the defect of poor absorption, so just developed rotundine hydrochloride tablet, to promote its absorption. An article about “(-)-Tetrahydropalmatine Monohydrate” published in Acta Crystallographica Section C, Volume 54, Issue 12, Page 1977, was retrieved from the literature [2] , which records the crystal structure of Luotong fixed crystal type A, whi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D455/03A61K31/4375A61P29/00A61P25/20A61P9/06
Inventor 杜冠华吕扬杨世颖强桂芬张恒艾应剑
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products